Furthermore, on TKI-sensitive cell lines, EGFR inhibition significantly reduced CD47 expression on the surface of preapoptotic cells, favoring more efficient engulfment of cancer cells by monocyte-derived dendritic cells [20]. The gene discussed is EGFR; the disease is cancer.